about
The phytochemical investigation of Agrimonia eupatoria L. and Agrimonia procera Wallr. as valid sources of Agrimoniae herba--The pharmacopoeial plant material.Activity-guided isolation, identification and quantification of biologically active isomeric compounds from folk medicinal plant Desmodium adscendens using high performance liquid chromatography with diode array detector, mass spectrometry and multiDual inhibition of metallopeptidases ACE and NEP by extracts, and iridoids from Ligustrum vulgare L.Extracts from Epilobium sp. herbs, their components and gut microbiota metabolites of Epilobium ellagitannins, urolithins, inhibit hormone-dependent prostate cancer cells-(LNCaP) proliferation and PSA secretion.Role of human gut microbiota metabolism in the anti-inflammatory effect of traditionally used ellagitannin-rich plant materials.Influence of gut microbiota-derived ellagitannins' metabolites urolithins on pro-inflammatory activities of human neutrophils.Phytochemistry, pharmacology and traditional uses of different Epilobium species (Onagraceae): a review.Lythrum salicaria L.-Underestimated medicinal plant from European traditional medicine. A review.Urolithins, gut microbiota-derived metabolites of ellagitannins, inhibit LPS-induced inflammation in RAW 264.7 murine macrophages.Contribution of C-glucosidic ellagitannins to Lythrum salicaria L. influence on pro-inflammatory functions of human neutrophils.Differences in Metabolism of Ellagitannins by Human Gut Microbiota ex Vivo Cultures.Oleacein. translation from Mediterranean diet to potential antiatherosclerotic drug.Extracts from Epilobium sp. herbs induce apoptosis in human hormone-dependent prostate cancer cells by activating the mitochondrial pathway.Phase II Conjugates of Urolithins Isolated from Human Urine and Potential Role of β-Glucuronidases in Their Disposition.Induction of neutral endopeptidase activity in PC-3 cells by an aqueous extract of Epilobium angustifolium L. and oenothein B.Establishment of hairy root cultures of Rhaponticum carthamoides (Willd.) Iljin for the production of biomass and caffeic acid derivativesOenothera paradoxa defatted seeds extract and its bioactive component penta-O-galloyl-β-D-glucose decreased production of reactive oxygen species and inhibited release of leukotriene B4, interleukin-8, elastase, and myeloperoxidase in human neutrophScreening of traditional European herbal medicines for acetylcholinesterase and butyrylcholinesterase inhibitory activity.Inhibition of human neutrophils NEP activity, CD11b/CD18 expression and elastase release by 3,4-dihydroxyphenylethanol-elenolic acid dialdehyde, oleacein.Effects of penta-O-galloyl-β-D-glucose on human neutrophil function: significant down-regulation of L-selectin expression.Synthesis of imperatorin analogs and their evaluation as acetylcholinesterase and butyrylcholinesterase inhibitors.Novel insight into qualitative standardization of Polygoni avicularis herba (Ph. Eur.).Oleuropein and oleacein may restore biological functions of endothelial progenitor cells impaired by angiotensin II via activation of Nrf2/heme oxygenase-1 pathway.Determination of C-glucosidic ellagitannins in Lythri salicariaeherba by ultra-high performance liquid chromatography coupled with charged aerosol detector: method development and validation.Hydroxycinnamoyl derivatives and secoiridoid glycoside derivatives from Syringa vulgaris flowers and their effects on the pro-inflammatory responses of human neutrophils.Bioassay-Guided Isolation of Iridoids and Phenylpropanoids from Aerial Parts of Lamium album and Their Anti-inflammatory Activity in Human Neutrophils.Novel biological properties of Oenothera paradoxa defatted seed extracts: effects on metallopeptidase activity.Effects of Geum urbanum L. root extracts and its constituents on polymorphonuclear leucocytes functions. Significance in periodontal diseases.Ellagitannins modulate the inflammatory response of human neutrophils ex vivo.Quantitative Determination of Secoiridoids and Phenylpropanoids in Different Extracts of Ligustrum Vulgare L. Leaves by a Validated HPTLC-Photodensitometry Method.High-performance thin-layer chromatography method for quantitative determination of oenothein B and quercetin glucuronide in aqueous extract of Epilobii angustifolii herba.Anti-hyaluronidase and anti-elastase activity screening of tannin-rich plant materials used in traditional Polish medicine for external treatment of diseases with inflammatory background.Seasonal variation in secondary metabolites of edible shoots of Buck's beard [Aruncus dioicus (Walter) Fernald (Rosaceae)].Oleacein may inhibit destabilization of carotid plaques from hypertensive patients. Impact on high mobility group protein-1.Effects of an aqueous extract from leaves of Ligustrum vulgare on mediators of inflammation in a human neutrophils model.Evaluation of the Effect of Epilobium angustifolium Aqueous Extract on LNCaP Cell Proliferation in In Vitro and In Vivo Models.Effects of Phytochemically Characterized Extracts From Syringa vulgaris and Isolated Secoiridoids on Mediators of Inflammation in a Human Neutrophil Model.Lignans From Forsythia x Intermedia Leaves and Flowers Attenuate the Pro-inflammatory Function of Leukocytes and Their Interaction With Endothelial Cells.Determination of the Phenolic Profile and Antioxidant Properties of L. Shoots: A Comparison of Aqueous and Hydroethanolic ExtractsInhibitory effect of Ligustrum vulgare leaf extract on the development of neuropathic pain in a streptozotocin-induced rat model of diabetes
P50
Q30316442-86871A68-ADD8-4F44-8D88-9B28C73C2323Q30854081-D2FBCAF6-D2C9-404A-852D-B1A406756603Q33369304-F09A6CBA-8C8A-44BD-A382-D13A0CFEC376Q34597708-0707A803-0D7E-4FA5-B115-E8EA3E38BC6AQ35196019-F54D521D-1F0B-47A8-81B1-7D24EF00636EQ35201262-59ACCCD3-C878-47C9-A7A3-0CABE9561446Q35241785-82006E73-37C2-4BBE-9A79-18403B2FC1D6Q35634335-4D05DD4E-4DC7-405C-B6FA-005DFBF43B76Q35706636-F17A3920-8B17-47A0-9C39-610DB5D414B2Q35981411-66D4465A-795A-46EE-B040-9CE0B79618F1Q36231843-A2A0FD5E-EDAA-4F16-9538-305C26DABDD3Q38259949-1283CBA8-EB7E-42AC-A5E0-094E6A28C222Q39143685-F1E00456-2786-45F4-ADCF-9D1447AD8F49Q40298757-FEF83D38-4031-4687-855E-9069DFA17B42Q40313414-2C50B10E-1EF6-4934-A8DB-A5C10D7E47DEQ41382054-93E2A3FB-7BD0-4CFA-AF04-4C01BA7DD8B5Q42932820-282662CD-8E17-48A6-8ED3-7F343C30E3F2Q43130335-CB72E9CC-3D09-49DA-B988-CE25D916C882Q43427010-4BCFB23A-9A4F-4D94-9F5B-A11878ABD452Q43524705-14827747-7FD0-4F91-BBB7-91A9051BFD44Q43532513-5FEA72F7-DCC3-4CB2-BD86-44178FF8848CQ43611130-AD4083C8-566A-4151-B723-80517B646BA8Q43781629-90EA11F9-553B-4020-BF37-7D92BC6F396DQ44299225-EBDCFCC0-9C17-4F03-8CCB-1B82813EAC1BQ46333057-34F5141C-3F00-42FE-A661-553543037C71Q46390960-FFD4FCE7-1B9C-4616-999A-5BD47C38AEB9Q46426590-768CA5D8-8E76-4325-9489-23AE7B4DD393Q46554345-53A63FA5-55E0-4181-9FD2-9DE96A2336F8Q46625613-087334EB-FF13-4429-9EC6-9E03CBE6E4A0Q46770722-E31870AB-E64B-4E04-B6CA-42711FE24D9BQ46916520-F5749A24-C991-4431-B7F6-5D9912FE4E04Q47290447-57BA9038-88CA-4C70-A8BC-454DAB68CB10Q50428871-2196B47A-8BC5-416C-8192-3ADBD4F0C603Q50523189-B5544AD4-4F03-400E-9CF3-4A8AD0C989ACQ50860281-A3BF6437-4FB9-427B-A356-A1AF56CDFD5BQ52666097-AA3A1668-7BAF-4420-95EC-99300D672EBCQ54114250-E65AFAF2-AE0B-4F37-A2A2-9945E54DA59FQ54979509-D42A677D-4C38-404E-BDE4-0DE077143FD3Q60429661-D843BBC3-C896-4D6F-82D0-77915A1CDE60Q60429665-68A0556D-CE18-4712-8B86-08102BF09CF6
P50
description
Polish pharmacologist
@en
polska farmakolog
@pl
wetenschapper
@nl
հետազոտող
@hy
name
Anna Kiss
@ast
Anna Kiss
@en
Anna Kiss
@es
Anna Kiss
@nl
Anna Kiss
@pl
type
label
Anna Kiss
@ast
Anna Kiss
@en
Anna Kiss
@es
Anna Kiss
@nl
Anna Kiss
@pl
altLabel
Anna Karolina Kiss
@pl
prefLabel
Anna Kiss
@ast
Anna Kiss
@en
Anna Kiss
@es
Anna Kiss
@nl
Anna Kiss
@pl
P214
P106
P1153
7201645987
P21
P214
P31
P3124
P496
0000-0001-8258-2849